To the full analysis
Buyback calculator for Neurogene
Neurogene stock: key metrics
NGNENeurogene had an operating margin of 0% and a return on invested capital (ROIC) of −27.2% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2011 | no data | no data | no data |
| 2012 | no data | no data | no data |
| 2013 | no data | no data | no data |
| 2014 | no data | no data | no data |
| 2015 | no data | no data | no data |
| 2016 | no data | no data | no data |
| 2017 | no data | no data | no data |
| 2018 | 100.0% | −94.1% | −126.3% |
| 2019 | no data | no data | no data |
| 2020 | no data | no data | no data |
| 2021 | no data | no data | no data |
| 2022 | no data | no data | no data |
| 2023 | no data | no data | no data |
| 2024 | −251.0% | −8,930.3% | −8,123.7% |
| 2025 | no data | no data | no data |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2011 | −100.0% | −88.8% | −100.0% |
| 2012 | −100.0% | no data | −100.0% |
| 2013 | −17.0% | −25.4% | −14.9% |
| 2014 | −65.9% | −38.2% | −57.5% |
| 2015 | −20.2% | −23.3% | −19.3% |
| 2016 | −25.6% | −78.6% | −24.0% |
| 2017 | −50.7% | −33.1% | −45.5% |
| 2018 | −43.5% | −21.6% | −40.7% |
| 2019 | −49.0% | −17.9% | −47.2% |
| 2020 | −17.4% | −19.0% | −15.8% |
| 2021 | 55.0% | −27.0% | −49.8% |
| 2022 | −56.0% | −45.9% | −50.5% |
| 2023 | −19.5% | −29.1% | −16.3% |
| 2024 | −24.2% | −24.9% | −22.4% |
| 2025 | −34.1% | −27.2% | −31.3% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Mar 2015)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.